Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CombiMatrix Corp (NASDAQ:CBMX)

1.15
Delayed Data
As of 10:31am ET
 +0.06 / +5.50%
Today’s Change
1.03
Today|||52-Week Range
2.16
-10.85%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Electronic Components
MARKET CAP
$13.8M

Company Description

CombiMatrix Corp. is a clinical diagnostic laboratory company, which provides cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It offers chromosomal microarray analysis, standard and customized FISH, and high resolution karyotyping to help clinicians better care for their patients. CombiMatrix was founded in October 1995 and is headquartered in Irvine, CA.

Contact Information

CombiMatrix Corp.
310 Goddard
Irvine California 92618
P:(949) 753-0624
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Mark D. McDonoughPresident, Chief Executive Officer & Director
Scott R. BurellCFO, Secretary, Treasurer & Head-Media Relations
Trilochan SahooVP-Clinical Affairs & Cytogenetics Director
Hisashi Sho FujiVice President-Engineering & Production
Karine HovanesVP-Scientific Advancement & Laboratory Director